轻链造脏病:Tamm-Horsfall蛋白免疫活性与临床病理特征和预后之间的关系
Ming-Yue Wang1,2,3,4,5,6, Zi-Hao Yong7, Shuang Wang1,2,3,4,5,6,8
1Renal Division, Department of Medicine, Peking University First Hospital, Beijing, PR China.
Kidney diseases (Basel, Switzerland)
|March 5, 2026
概括
在轻链造脏病 (LCCN) 中,Tamm-Horsfall蛋白 (THP) 并非总是存在的. THP阴性LCCN与更严重的损伤和贫血有关,强调需要仔细的诊断评估.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 病理学 病理学 病理学
- 在瘤学瘤学.
背景情况:
- 轻链造脏病 (LCCN) 是由单克隆轻链和Tamm-Horsfall蛋白 (THP) 形成阻塞性脏造物引起的.
- 在各种形式的LCCN中THP的具体作用尚未完全理解.
- 以前的研究表明,一些LCCN变体可能独立于THP形成.
研究的目的:
- 调查THP在各种LCCN变异中的参与.
- 为了比较THP阳性和THP阴性LCCN患者组之间的临床病理特征和结果.
主要方法:
- 对32名多发性骨髓瘤和活检证明的LCCN.患者的回顾性分析.
- 根据免疫组织化学,分类为THP阳性 (n=19) 和THP阴性 (n=13) 组.
- 临床,实验室和组织病理学数据的比较,并补充了造成分的蛋白质组分析.
主要成果:
- 阴性THP的LCCN (40.6%的病例) 显示血红蛋白显著降低,肌素更高,性损伤 (AKI) 更严重,透析依赖性更大.
- 阴性THP患者表现出更严重的管道缩,间歇性炎症和急性管道损伤.
- 蛋白质组分析证实,在一些THP阴性体中没有THP;两组之间没有生存差异.
结论:
- THP阴性LCCN与严重的贫血,需要透析的AKI和显著的管道损伤有关.
- 建议对LCCN患者进行THP免疫组织化学的仔细评估.
- 进一步研究LCCN的病原性是有必要的.
更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
1.0K
10:15Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
2.2K
相关概念视频
01:24Nephrotic Syndrome I : Introduction
787
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
787
01:26Nephrotic Syndrome II : Assessment and Medical Management
285
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
285
01:24Chronic Kidney Disease II: Clinical Manifestations
829
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
829
01:24Nephrotic Syndrome III : Nursing Management
402
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
402
01:28Chronic Kidney Disease III: Interprofessional Care
558
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
558